MONTREAL, June 12 /CNW Telbec/ - ORTHOsoft Inc. (TSX-V: OSH), a leader in
computer-assisted surgery systems that increase the accuracy of orthopaedic
hip and knee replacement procedures, cordially invites you to an ORTHOsoft
Inc. product presentation as part of its annual shareholders meeting, with
special guest, Dr. Pascal-A Vendittoli MD, MSc, FRCS, user of ORTHOsoft Inc.
computer-assisted orthopaedic surgical systems.
Friday, June 15, at 9 a.m.
The Fairmont Queen Elizabeth, Hotel Gatineau Room
900 René-Levesque Blvd. W.
Dr. Louis-Phillipe Amiot, Founder, President and CEO
Peggy Katsiroumbas, V.P. of Finance
Yvan Beaudoin, Chief of Operations
Special guest: Dr. Pascal-A. Vendittoli MD, MSc, FRCS
Subjects to be discussed:
- Accomplishments for 2006-2007
- New products launched to facilitate orthopaedic surgery, especially
knee and hip procedures
- Presentation by Dr. Vendittoli on the benefits of surgical navigation
systems for patients, surgeons and hospitals
- Surgical navigation system demonstration
- Overview of the surgical navigation system market in Europe and North
- Is the 3rd largest surgical navigation system provider in North America
- Is the only company in the world to specialize in orthopaedic surgical
- Has performed over 60,000 orthopaedic procedures with its navigation
systems since 1996
- Employs over 80 people
- Generated $12.7 million in revenues in 2006
Those in attendance will be available for interviews at the end of the
meeting. To receive a biography or any other document, contact Dominic Sicotte
The meeting will be broadcast on the Internet and can be accessed via
www.orthosoft.ca and www.cnw.ca.
Founded in 1995, ORTHOsoft Inc. (TSX-Venture: OSH) develops and markets
best-in-class medical software, instruments and computerized systems designed
to help orthopaedic surgeons increase accuracy in hip, knee and spine implant
surgery. ORTHOsoft's FDA-approved patented software solutions are developed by
surgeons for surgeons, resulting in intuitive and easy-to-use navigation that
tracks surgical flow and provides surgeons with real-time data, thus helping
to improve the surgical process and patient outcomes. For further information,
The TSX Venture Exchange does not accept responsibility for the adequacy
or accuracy of this release.
Certain statements contained in this news release, other than statements
of fact that are independently verifiable at the date hereof, may constitute
forward-looking statements. Such statements, inherently involve numerous risks
and uncertainties, known and unknown, many of which are beyond the control of
ORTHOsoft, Inc. Such risks include, but are not limited to: the impact of
general economic conditions, general conditions in the medical industry, and
changes to the competitive environment in the jurisdictions in which ORTHOsoft
does business, regulatory changes to the health care industry, and adequate
protection of the proprietary interests of the Company. Consequently, actual
future results may differ materially from the anticipated results expressed in
the forward-looking statements. The reader should not place undue reliance on
the forward-looking statements included in this press release. These
statements speak only as of the date made, and ORTHOsoft is under no
obligation and disavows any intention to update or revise such statements as a
result of any event, circumstances, or otherwise.
For further information:
For further information: Investors and media: Dominic Sicotte, Echoes
Financial Network Inc., (866) 633-9551, email@example.com